Semaglutide Before and After: Weight Loss Results by Month

People taking semaglutide 2.4mg (Wegovy) lost an average of 14.9-17% of their body weight over 68 weeks in the landmark STEP clinical trials: roughly 35 lbs for a 230-lb person. In March 2026, the FDA approved a higher dose: Wegovy HD (7.2mg) produced 20.7% mean weight loss at 72 weeks in the STEP UP trial, bringing semaglutide's ceiling close to tirzepatide's best results. Weight loss follows a predictable curve: modest in months 1-2 as the dose ramps up, accelerating through months 3-6, and plateauing around months 12-16. One-third of standard-dose Wegovy participants lost 20%+ of their body weight; on Wegovy HD, that rises to 31%. Here's a month-by-month breakdown backed by published trial data. See providers ranked by lowest semaglutide price, or take the match quiz.

Semaglutide Weight Loss Timeline: Month by Month

Semaglutide is prescribed as a once-weekly injection with a gradual dose increase over 16-20 weeks. Weight loss tracks closely with the dose escalation, here's what the clinical data shows:

STEP Trial Results: The Clinical Evidence

The STEP (Semaglutide Treatment Effect in People with Obesity) trials are the largest and most rigorous studies of semaglutide for weight loss. Here's what each trial found:

The most important finding: the STEP 4 withdrawal study showed that patients regained approximately two-thirds of their lost weight within one year of stopping semaglutide. This confirms that semaglutide works as ongoing treatment, not a short-term fix.

What Affects Your Results?

Clinical trial averages don't tell the whole story. Several factors influence how much weight you'll lose on semaglutide:

• •Starting weight, People with higher starting BMI tend to lose a larger absolute amount of weight, though percentage loss is similar across weight ranges.
• •Dose reached, The 2.4mg maintenance dose produced the best results in trials. Some patients can't tolerate the full dose and stay at 1.0mg or 1.7mg, which produces less weight loss (approximately 10-12%).
• •Diet and exercise, The STEP 3 trial added intensive behavioral therapy (diet counseling + exercise) and achieved 16% weight loss vs 14.9% in STEP 1 with medication alone.
• •Type 2 diabetes, Patients with T2 diabetes lost less weight (9.6% in STEP 2 vs 14.9% in STEP 1), likely due to insulin resistance and diabetes medications that promote weight gain.
• •Genetics and metabolism, About 10-15% of trial participants were classified as 'non-responders' who lost less than 5% body weight despite full dosing. There's no reliable way to predict this in advance.
• •Consistency, Missing doses reduces efficacy. The weekly injection schedule must be maintained consistently for optimal results.

Semaglutide vs Tirzepatide: Which Produces Better Results?

If you're comparing options, tirzepatide (Zepbound/Mounjaro) produces significantly more weight loss than semaglutide in head-to-head trials:

At standard doses, tirzepatide still outperforms semaglutide, but Wegovy HD narrows the gap significantly. Read our full Wegovy vs Zepbound comparison or see tirzepatide cost breakdown for pricing details.

Oral GLP-1 Weight Loss Results: Pills vs Injections

Two FDA-approved oral GLP-1 pills for weight loss are now available alongside injectable semaglutide. The pills produce clinically significant weight loss but show meaningful differences from injections in both efficacy and convenience. Here's how the Phase 3 data compares across every form:

The practical decision: Oral Wegovy produced 16.6% in OASIS and requires a 30-minute fast; Foundayo produced 12.4% in ATTAIN-1 and has no fasting requirement. Those separate-trial averages are not a head-to-head result. Both cash-pay floors start at $149/month, but Foundayo's price rises by dose/refill timing and NovoCare describes Wegovy as dose-dependent. Compare your prescribed-dose total and coverage in our oral GLP-1 guide.

What Happens When You Stop Semaglutide?

The STEP 4 trial directly studied what happens after discontinuation, and the results are sobering. After achieving 17.4% weight loss over 20 weeks, participants who switched to placebo regained approximately two-thirds of their lost weight over the following year. Those who continued semaglutide maintained their weight loss.

This doesn't mean semaglutide is a failure, it means obesity is a chronic condition that requires ongoing treatment, similar to blood pressure medication. The American Medical Association and the Obesity Medicine Association both classify obesity as a chronic disease requiring long-term management.

How Do You Maximize Semaglutide Results?

• •Follow the dose escalation schedule, Don't rush to the maintenance dose. The gradual increase (0.25mg → 0.5mg → 1.0mg → 1.7mg → 2.4mg over 16-20 weeks) reduces side effects and improves long-term adherence.
• •Prioritize protein intake, GLP-1 medications can cause muscle loss alongside fat loss. Aim for 0.7-1.0g protein per pound of body weight daily to preserve lean mass. The STEP 3 trial included dietary guidance and saw better outcomes.
• •Add resistance training, Weight-bearing exercise helps preserve muscle during rapid weight loss. Even 2-3 sessions per week makes a measurable difference in body composition.
• •Stay hydrated, Semaglutide slows gastric emptying, which can cause constipation. Drinking 80+ oz of water daily helps manage this common side effect.
• •Track your progress monthly, not weekly, Weight fluctuates daily due to water retention, food timing, and hormonal cycles. Monthly measurements give a more accurate picture of your trajectory.
• •Communicate with your provider, If nausea persists beyond the first month or weight loss stalls, your provider can adjust timing, suggest anti-nausea strategies, or modify your dose. Our dosing timeline tool shows what a typical titration schedule looks like.

Getting Started: Cheapest Semaglutide Options

If you're ready to start semaglutide, here are the most affordable ways to access it in 2026:

• •Low-cost compounded tirzepatide (note: bulk compounded semaglutide was banned by FDA in 2025): Enhance MD starts at $99 first month ($280/mo after), Shed at $299/mo, and Sprout Health at $199 first month ($249/mo after). See all providers ranked by price.
• •Mid-range with more support: Sprout Health ($199 first month, then $249/mo) includes a dedicated care coordinator and published outcomes data, the most clinically supported active partner in our table.
• •Brand-name with insurance: If your insurance covers Wegovy, apply for the Novo Nordisk savings card for $25/month copays. Wegovy HD (7.2mg, approved March 2026, 20.7% loss) is also available via NovoCare for patients who want the highest semaglutide dose.
• •Prefer pills over injections? Oral semaglutide is available as the Wegovy pill (from $149/mo manufacturer-direct; savings eligibility varies), while Foundayo starts at $149/mo at 0.8 mg and follows a dose/refill ladder to $349 with no fasting. See our oral GLP-1 guide.
• •Medicare: As of July 1, 2026, Part D covers Wegovy (including Wegovy HD) at $50/month through the GLP-1 Bridge Demonstration. See our Medicare GLP-1 coverage guide.
• •Not sure which provider? Take our 7-question match quiz to find the best provider for your budget, insurance status, and preferences.

Frequently Asked Questions

How much weight will I lose on semaglutide in 3 months? Based on the STEP trials, most patients lose 5-8% of their body weight in the first 3 months (roughly 12-18 lbs for a 230-lb person). You'll still be ramping up to the maintenance dose during this period, so weight loss accelerates after month 3.

Do semaglutide results last? As long as you continue treatment, yes. The STEP 5 trial showed sustained weight loss over 2 full years of treatment. However, stopping semaglutide typically leads to weight regain, the STEP 4 withdrawal study showed approximately two-thirds of lost weight returned within one year of stopping.

Is semaglutide worth it? For most patients with a BMI of 30+ (or 27+ with comorbidities), semaglutide produces significant, clinically meaningful weight loss with manageable side effects. The STEP trials showed improvements in blood pressure, blood sugar, triglycerides, and waist circumference alongside weight loss. The main consideration is cost and the commitment to long-term use.

What is Wegovy HD and how much weight can I lose on it? Wegovy HD is semaglutide 7.2mg: a higher dose approved by the FDA on March 20, 2026. In the STEP UP trial, 7.2mg produced 20.7% average weight loss at 72 weeks, compared to 17.5% for the standard 2.4mg dose in the same study. About 31% of Wegovy HD patients lost 25%+ of their body weight. The higher dose comes with more potential for nausea and GI side effects, particularly during the additional dose-escalation steps. Wegovy HD is available via NovoCare.

What are the most common side effects? Nausea (44%), diarrhea (30%), vomiting (24%), and constipation (24%) were the most common in STEP 1. Most side effects occur during dose escalation and resolve within 4-8 weeks. Read our GLP-1 side effects management guide for detailed strategies.

Sources